Market Access Agenda in Europe with Prof. Dr. Matthias P. Schönermark by Oznur Seyhun
Join us for an insightful discussion with Prof. Dr. Matthias P. Schönermark, Owner of SKC Beratungsgesellschaft mbH, as he shares his expertise and experiences in an exclusive interview with Oznur Seyhun, Partner & Anchorwoman at Market Access Today.
In This Video:
Introduction to Prof. Dr. Matthias P. Schönermark: Discover the impressive career journey of Prof. Schönermark and his significant contributions to the field of health technology assessment (HTA).
Impact of European HTA Regulation: With the European Health Technology Assessment Regulation now effective for oncology drugs and advanced therapy medicinal products, Prof. Schönermark discusses the anticipated impacts on industry practices and patient access.
Implications of the Implementing Act: After some delays, the Implementing Act on the Design of Joint Clinical Assessments was recently published in April. Learn about its implications and how it is prepared to enhance the implementation of the European HTA Regulation across Member States.
Future Trends in Patient Access: Prof. Schönermark outlines the trends he foresees in Europe regarding securing adequately funded patient access and how he sees the European HTA fitting within the broader organization.
Stay Connected: 📅 Release Date: 03.06.204 🔔 Subscribe and hit the bell icon to stay updated with our latest content!
To follow us and stay tuned, please visit our LinkedIn page! Don’t miss this engaging!
interview packed with valuable insights from a leading expert in the field of health technology assessment.
Video edited by Yasemin Simit.
#marketaccess #medicaldevice #pharmaceutical #hta #pharmacoeconomics
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
